These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10825999)

  • 21. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin.
    Boo I; Fischer AE; Johnson D; Chin R; Giourouki M; Bharadwaj M; Bowden S; Torresi J; Drummer H
    J Clin Virol; 2007 Aug; 39(4):288-94. PubMed ID: 17569577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus (HCV)--a review molecular biology of the virus, immunodiagnostics, genomic heterogeneity and the role of virus in hepatocellular carcinoma.
    Poduri CD
    Indian J Exp Biol; 2003 Jun; 41(6):549-62. PubMed ID: 15266899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of chronic hepatitis C virus infection: a new era of disease control.
    Teoh NC; Farrell GC
    Intern Med J; 2004 Jun; 34(6):324-37. PubMed ID: 15228394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
    Romero-Gómez M; González-Escribano MF; Torres B; Barroso N; Montes-Cano MA; Sánchez-Muñoz D; Núñez-Roldan A; Aguilar-Reina J
    Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drug targets for HIV and hepatitis C virus coinfection.
    Tedaldi EM
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S101-4. PubMed ID: 16265606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing chronic hepatitis C in relapsers and non-responders.
    Montalbano M; Kemmer N; Neff GW
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):31-47. PubMed ID: 18299666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
    J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in hepatitis C.
    Cecil B; Lavelle M
    J Ky Med Assoc; 2000 Oct; 98(10):440-4. PubMed ID: 11059215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of hepatitis C virus infection.
    Mondelli MU
    J Biol Regul Homeost Agents; 2003; 17(2):128-32. PubMed ID: 14518710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinician's guide to hepatitis C.
    Gross JB
    Mayo Clin Proc; 1998 Apr; 73(4):355-60; quiz 361. PubMed ID: 9559040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon in chronic hepatitis in patients infected by the human immunodeficiency virus: yes or no?].
    Soriano V; García-Samaniego J
    Med Clin (Barc); 1992 Oct; 99(12):459-61. PubMed ID: 1281247
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis C virus infection].
    Chayama K; Kumada H
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):55-8. PubMed ID: 10088336
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic hepatitis C].
    Olaso Peiró V; Córdoba Cortijo J; Prieto Castillo M
    Rev Esp Enferm Dig; 1997 Aug; 89(8):621-37. PubMed ID: 9471204
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of chronic hepatitis C.
    García-Tsao G
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S52-3. PubMed ID: 8948779
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis C, therapy and predicting factors].
    Zamir D; Zamir C; Weiner P
    Harefuah; 1997 May; 132(9):643-8. PubMed ID: 9225580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.